ERIBULINE ADVANZ PHARMA 0 (ERIBULINE) QT Prolongation Risk & TQT Data

ERIBULINE ADVANZ PHARMA 0

✓ VERIFIED BY DOCTOR

Active Ingredient: ERIBULINE

QTc Interval Status:

prolongation

(Hérité de ERIBULINE BAXTER 0)

https://www.fda.gov/media/178811/download, https://doi.org/10.18632/oncotarget.25008, https://doi.org/10.1016/S1470-2045(22)00221-2